How Many Products Are In Development For Neglected Tropical Diseases? BVGH Takes A Closer Look
This article was originally published in PharmAsia News
In a recent report, the nonprofit BIO Ventures for Global Health shines a light on the NTD pipelines of Big Pharma, biotechs and others.
You may also be interested in...
TB Alliance plans to seek FDA approval for its treatment regimen, which is beginning a Phase IIb trial, as the agency looks to respond to calls for a clearer and quicker pathway for NTD drugs.
Regulators in Southeast Asia are working to tighten bribery and corruption enforcement as part of a broader push ahead of an Association of Southeast Asian Nations trade pact in 2015 for greater transparency in pharmaceuticals.
The first commercial implant for St. Jude’s Allure Quadra in Hong Kong is a sign for optimism for its pacemaker business after last year’s disappointments in Japan.